Back Pfizer Afrikaans فايزر Arabic فايزر ARZ Pfizer AST Pfizer Azerbaijani فایزر AZB Pfizer BAT-SMG Файзър Bulgarian ফাইজার Bengali/Bangla Pfizer BS
.svg) Logo used since 2021 | |
| Company type | Public |
|---|---|
| Industry | |
| Founded | 1849 in New York City |
| Founders | |
| Headquarters | The Spiral, New York City , US |
Area served | Worldwide |
Key people | Albert Bourla (Chairman and CEO) |
| Products | |
| Revenue |  US$63.63 billion (2024) |
| US$12.41 billion (2024) | |
| US$8.031 billion (2024) | |
| Total assets |  US$213.4 billion (2024) |
| Total equity | US$88.20 billion (2024) |
Number of employees | 81,000 (2024) |
| Website | www |
| Footnotes / references [1] | |
Pfizer Inc. (/ˈfaɪzər/ FY-zər)[2] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer (1824–1906) and Charles F. Erhart (1821–1891), Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in 2023 revenues), a pneumococcal conjugate vaccine ($6 billion in 2023 revenues), palbociclib ($4 billion in 2023 revenues), and tafamidis ($3 billion in 2023 revenues).[3] In 2023, 46% of the company's revenues came from the United States, 6% came from Japan, and 48% came from other countries.[3]
Pfizer has been a publicly traded company for nearly a century, making its debut on the New York Stock Exchange in 1942 under the ticker symbol PFE. Pfizer is part of major stock indices like the S&P 100 and S&P 500, having major institutional investors.[4]
Pfizer is one of the top pharmaceutical companies in the United States, with a market capitalization of $150.35 billion as of December 31, 2024. It ranks fifth among U.S. pharma companies. As of 2024, the company holds the 69th position on the Fortune 500 list.[5][6]
- ^ "Pfizer Inc. 2024 Form 10-K Annual Report". U.S. Securities and Exchange Commission. February 27, 2025.
- ^ Wells, John C. (2008), Longman Pronunciation Dictionary (3rd ed.), Longman, ISBN 9781405881180
- ^ a b "Pfizer Inc. 2023 Form 10-K Annual Report". U.S. Securities and Exchange Commission. February 22, 2024.
- ^ "Pfizer Inc. (PFE)". finance.yahoo.com. Retrieved February 10, 2025.
- ^ "Fortune 500: Pfizer". Fortune.
- ^ "Top 10 Pharma Companies in the US by Market Capitalization". globaldata.com. Retrieved February 10, 2025.